Anti-HY13743 monoclonal antibody
Alternative Names: HY 13743; Monoclonal antibody HY13743Latest Information Update: 02 Jul 2004
At a glance
- Originator Nuvelo
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 02 Jul 2004 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 19 Feb 2003 Hyseq Pharmaceuticals has merged with Variagenics to form Nuvelo
- 16 Jul 2002 Preclinical trials in Cancer in USA (unspecified route)